UPDATE 1-Bristol-Myers says Starboard nominated five directors, bought shares
February 20, 2019 at 11:45 AM EST
Bristol-Myers Squibb Co said on Wednesday that activist hedge fund Starboard Value LP intends to nominate five directors to the U.S. drugmaker's board, one month after it announced a $74 billion deal to acquire peer Celgene Corp.
